ZyVersa Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q1 2023 to Q2 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
ZyVersa Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2023 to Q2 2024.
  • ZyVersa Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending August 8, 2024 was 1.03M shares.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 1.03M Aug 8, 2024 10-Q 2024-08-09
Q1 2024 7.59M -1.62M -17.6% Mar 21, 2024 10-K 2024-03-25
Q3 2023 43.5M Nov 10, 2023 10-Q 2023-11-14
Q1 2023 9.21M Mar 23, 2023 10-K 2023-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.